Arcutis Biotherapeutics Inc (ARQT)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-04-03 | 2025-04-02 | S Sale |
Chief Financial Officer Officer |
1,000
-5.0%
15.80USD 151,698 |
1,000 -5.0% | 15.80 | USD 100,000 | |
| 2025-04-03 | 2025-04-01 | PS Planned sale | Non-Executive Director |
1,000
-7.6%
15.12USD 151,236 |
1,000 -7.6% | 15.12 | USD 100,000 | |
| 2025-03-26 | 2025-03-25 | PS Planned sale |
See Remarks Executive Director |
2,171
-0.2%
17.56USD 38,131 |
2,171 -0.2% | 17.56 | USD 38,131 | |
| 2025-03-26 | 2025-03-24 | PS Planned sale |
See Remarks Executive Director |
1,500
-0.2%
17.52USD 26,282 |
1,500 -0.2% | 17.52 | USD 26,282 | |
| 2025-03-20 | 2025-03-17 | PS Planned sale |
See Remarks Executive Director |
1,200
-0.1%
17.61USD 21,137 |
1,200 -0.1% | 17.61 | USD 21,137 | |
| 2025-03-17 | 2025-03-14 | S Sale |
See Remarks Officer |
12,242
-9.1%
15.04USD 184,107 |
12,242 -9.1% | 15.04 | USD 184,107 | |
| 2025-03-17 | 2025-03-13 | S Sale |
See Remarks Officer |
5,008
-3.9%
15.10USD 75,631 |
5,008 -3.9% | 15.10 | USD 75,631 | |
| 2025-03-17 | 2025-03-13 | PS Planned sale |
See Remarks Officer |
44,153
-26.6%
14.97USD 660,772 |
44,153 -26.6% | 14.97 | USD 660,772 | |
| 2025-03-04 | 2025-03-04 | S Sale |
See Remarks Officer |
954
-0.6%
13.28USD 12,673 |
954 -0.6% | 13.28 | USD 12,673 | |
| 2025-03-04 | 2025-03-04 | S Sale |
See Remarks Executive Director |
4,135
-0.4%
13.28USD 54,930 |
4,135 -0.4% | 13.28 | USD 54,930 | |
| 2025-03-04 | 2025-03-03 | S Sale |
See Remarks Officer |
2,819
-1.7%
13.03USD 36,735 |
2,819 -1.7% | 13.03 | USD 36,735 | |
| 2025-03-04 | 2025-03-03 | S Sale |
See Remarks Executive Director |
20,880
-2.2%
13.03USD 272,089 |
20,880 -2.2% | 13.03 | USD 272,089 | |
| 2025-03-04 | 2025-03-03 | S Sale |
See Remarks Officer |
3,263
-1.5%
13.03USD 42,520 |
3,263 -1.5% | 13.03 | USD 42,520 | |
| 2025-03-04 | 2025-03-03 | PS Planned sale | Non-Executive Director |
10,000
-7.0%
13.00USD 130,048 |
10,000 -7.0% | 13.00 | USD 130,048 | |
| 2025-02-04 | 2025-02-03 | PS Planned sale |
See Remarks Officer |
2,173
-1.6%
12.70USD 27,597 |
2,173 -1.6% | 12.70 | USD 27,597 | |
| 2025-02-04 | 2025-02-03 | PS Planned sale |
See Remarks Officer |
8,338
-4.5%
12.70USD 105,893 |
8,338 -4.5% | 12.70 | USD 105,893 | |
| 2025-02-04 | 2025-02-03 | PS Planned sale | Non-Executive Director |
10,000
-6.6%
12.71USD 127,100 |
10,000 -6.6% | 12.71 | USD 127,100 | |
| 2025-02-04 | 2025-02-03 | S Sale |
See Remarks Executive Director |
19,301
-2.3%
12.70USD 245,123 |
19,301 -2.3% | 12.70 | USD 245,123 | |
| 2025-02-04 | 2025-02-03 | S Sale |
See Remarks Officer |
12,116
-9.5%
12.70USD 153,873 |
12,116 -9.5% | 12.70 | USD 153,873 | |
| 2025-01-06 | 2025-01-02 | PS Planned sale | Non-Executive Director |
10,000
-6.2%
14.67USD 146,714 |
10,000 -6.2% | 14.67 | USD 146,714 | |
| 2024-12-31 | 2024-12-31 | S Sale |
See Remarks Officer |
1,691
-1.3%
14.00USD 23,674 |
1,691 -1.3% | 14.00 | USD 23,674 | |
| 2024-12-23 | 2024-12-20 | PS Planned sale |
See Remarks Executive Director |
15,000
-1.8%
15.17USD 227,567 |
15,000 -1.8% | 15.17 | USD 227,567 | |
| 2024-12-03 | 2024-12-02 | PS Planned sale | Non-Executive Director |
10,000
-5.8%
12.51USD 125,133 |
10,000 -5.8% | 12.51 | USD 125,133 | |
| 2024-12-03 | 2024-11-30 | PP Planned purchase |
See Remarks Officer |
1,657
+0.9%
7.11USD 11,775 |
1,657 +0.9% | 7.11 | USD 11,775 | |
| 2024-12-03 | 2024-11-30 | PP Planned purchase |
See Remarks Officer |
1,093
+0.8%
7.11USD 7,767 |
1,093 +0.8% | 7.11 | USD 7,767 | |
| 2024-12-03 | 2024-11-30 | PP Planned purchase |
See Remarks Executive Director |
2,038
+0.2%
7.11USD 14,482 |
2,038 +0.2% | 7.11 | USD 14,482 | |
| 2024-11-26 | 2024-11-22 | S Sale |
See Remarks Officer |
16,023
-11.1%
10.14USD 162,515 |
16,023 -11.1% | 10.14 | USD 162,515 | |
| 2024-11-19 | 2024-11-19 | S Sale |
See Remarks Officer |
1,775
-1.0%
9.68USD 17,190 |
1,775 -1.0% | 9.68 | USD 17,190 | |
| 2024-11-18 | 2024-11-15 | S Sale |
See Remarks Officer |
100
-0.1%
10.03USD 1,003 |
100 -0.1% | 10.03 | USD 1,003 | |
| 2024-11-18 | 2024-11-14 | S Sale |
See Remarks Officer |
18,377
-12.5%
10.29USD 189,182 |
18,377 -12.5% | 10.29 | USD 189,182 | |
| 2024-11-18 | 2024-11-14 | S Sale |
See Remarks Officer |
50,749
-28.3%
10.29USD 522,436 |
50,749 -28.3% | 10.29 | USD 522,436 | |
| 2024-11-13 | 2024-11-11 | S Sale | Non-Executive Director |
8,687
-46.1%
10.85USD 94,238 |
8,687 -46.1% | 10.85 | USD 94,238 | |
| 2024-11-05 | 2024-11-04 | S Sale |
See Remarks Officer |
5,015
-2.7%
8.68USD 43,551 |
5,015 -2.7% | 8.68 | USD 43,551 | |
| 2024-11-05 | 2024-11-04 | S Sale |
See Remarks Officer |
15,441
-7.9%
8.68USD 134,093 |
15,441 -7.9% | 8.68 | USD 134,093 | |
| 2024-11-05 | 2024-11-04 | S Sale |
See Remarks Executive Director |
13,871
-1.6%
8.68USD 120,459 |
13,871 -1.6% | 8.68 | USD 120,459 | |
| 2024-11-05 | 2024-11-01 | PS Planned sale | Non-Executive Director |
10,000
-5.5%
8.65USD 86,541 |
10,000 -5.5% | 8.65 | USD 86,541 | |
| 2024-10-03 | 2024-10-02 | S Sale |
SVP Chief Commercial Officer Officer |
3,725
-2.7%
10.01USD 37,295 |
3,725 -2.7% | 10.01 | USD 37,295 | |
| 2024-10-03 | 2024-10-01 | PS Planned sale | Non-Executive Director |
10,000
-5.2%
9.26USD 92,616 |
10,000 -5.2% | 9.26 | USD 92,616 | |
| 2024-09-25 | 2024-09-24 | S Sale |
Chief Financial Officer Officer |
11,626
-6.8%
9.48USD 110,264 |
11,626 -6.8% | 9.48 | USD 110,264 | |
| 2024-09-05 | 2024-09-03 | PS Planned sale | Non-Executive Director |
10,000
-5.0%
10.77USD 107,695 |
10,000 -5.0% | 10.77 | USD 107,695 | |
| 2024-08-21 | 2024-08-19 | S Sale |
See Remarks Officer |
1,728
-0.9%
8.29USD 14,318 |
1,728 -0.9% | 8.29 | USD 14,318 | |
| 2024-08-05 | 2024-08-02 | PS Planned sale |
See Remarks Officer |
13,206
-6.3%
9.02USD 119,106 |
13,206 -6.3% | 9.02 | USD 119,106 | |
| 2024-08-05 | 2024-08-02 | PS Planned sale |
See Remarks Executive Director |
14,487
-1.7%
9.02USD 130,648 |
14,487 -1.7% | 9.02 | USD 130,648 | |
| 2024-08-05 | 2024-08-02 | PS Planned sale |
See Remarks Officer |
5,220
-2.8%
9.02USD 47,064 |
5,220 -2.8% | 9.02 | USD 47,064 | |
| 2024-08-05 | 2024-08-01 | PS Planned sale | Non-Executive Director |
3,386
-1.9%
9.87USD 33,418 |
3,386 -1.9% | 9.87 | USD 33,418 | |
| 2024-08-05 | 2024-08-01 | PS Planned sale | Non-Executive Director |
6,614
-3.5%
9.87USD 65,278 |
6,614 -3.5% | 9.87 | USD 65,278 | |
| 2024-07-02 | 2024-07-01 | S Sale | Non-Executive Director |
10,000
-5.3%
9.31USD 93,141 |
10,000 -5.3% | 9.31 | USD 93,141 | |
| 2024-06-06 | 2024-06-04 | S Sale | Non-Executive Director |
6,458
-3.7%
8.01USD 51,756 |
6,458 -3.7% | 8.01 | USD 51,756 | |
| 2024-06-06 | 2024-06-04 | S Sale | Non-Executive Director |
3,542
-2.0%
8.00USD 28,336 |
3,542 -2.0% | 8.00 | USD 28,336 | |
| 2024-12-03 | 2024-05-31 | PP Planned purchase |
See Remarks Officer |
4,000
+2.2%
1.69USD 6,768 |
4,000 +2.2% | 1.69 | USD 6,768 | |
| 2024-12-03 | 2024-05-31 | PP Planned purchase |
See Remarks Executive Director |
4,000
+0.5%
1.69USD 6,768 |
4,000 +0.5% | 1.69 | USD 6,768 | |
| 2024-05-31 | 2024-05-30 | S Sale |
See Remarks Officer |
23,000
-9.9%
8.75USD 201,319 |
23,000 -9.9% | 8.75 | USD 201,319 | |
| 2024-05-31 | 2024-05-29 | S Sale |
See Remarks Officer |
49,952
-19.2%
8.72USD 435,387 |
49,952 -19.2% | 8.72 | USD 435,387 | |
| 2024-05-29 | 2024-05-28 | S Sale |
See Remark Officer |
1,775
-0.9%
9.01USD 15,988 |
1,775 -0.9% | 9.01 | USD 15,988 | |
| 2024-05-20 | 2024-05-17 | S Sale |
SVP Chief Commercial Officer Officer |
7,640
-5.2%
8.98USD 68,582 |
7,640 -5.2% | 8.98 | USD 68,582 | |
| 2024-05-20 | 2024-05-17 | S Sale |
SVP Chief Commercial Officer Officer |
7,640
-5.2%
8.98USD 68,582 |
7,640 -5.2% | 8.98 | USD 68,582 | |
| 2024-05-03 | 2024-05-02 | S Sale |
SVP and Chief Business Officer Officer |
4,681
-3.1%
8.74USD 40,902 |
4,681 -3.1% | 8.74 | USD 40,902 | |
| 2024-05-03 | 2024-05-02 | PS Planned sale |
See Remarks Executive Director |
13,783
-1.6%
8.74USD 120,433 |
13,783 -1.6% | 8.74 | USD 120,433 | |
| 2024-05-03 | 2024-05-02 | PS Planned sale |
See Remark Officer |
5,016
-2.6%
8.74USD 43,829 |
5,016 -2.6% | 8.74 | USD 43,829 | |
| 2024-05-03 | 2024-05-02 | PS Planned sale |
See Remarks Officer |
9,555
-3.5%
8.74USD 83,490 |
9,555 -3.5% | 8.74 | USD 83,490 | |
| 2024-03-06 | 2024-03-04 | PS Planned sale |
See Remark Officer |
3,760
-1.9%
11.12USD 41,816 |
3,760 -1.9% | 11.12 | USD 41,816 | |
| 2024-03-06 | 2024-03-04 | PS Planned sale |
See Remarks Officer |
4,782
-1.7%
11.12USD 53,182 |
4,782 -1.7% | 11.12 | USD 53,182 | |
| 2024-03-06 | 2024-03-04 | B Purchase | Non-Executive Director |
21,052
+0.2%
9.50USD 199,994 |
21,052 +0.2% | 9.50 | USD 199,994 | |
| 2024-03-06 | 2024-03-04 | PS Planned sale |
SVP and Chief Business Officer Officer |
3,468
-2.3%
11.12USD 38,568 |
3,468 -2.3% | 11.12 | USD 38,568 | |
| 2024-03-06 | 2024-03-04 | PS Planned sale |
See Remarks Executive Director |
14,903
-1.7%
11.12USD 165,739 |
14,903 -1.7% | 11.12 | USD 165,739 | |
| 2024-03-01 | 2024-02-28 | PS Planned sale |
See Remarks Executive Director |
2,465
-0.3%
10.60USD 26,129 |
2,465 -0.3% | 10.60 | USD 26,129 | |
| 2024-01-03 | 2024-01-02 | S Sale |
See Remarks Officer |
1,325
-2.3%
3.54USD 4,692 |
1,325 -2.3% | 3.54 | USD 4,692 | |
| 2023-11-21 | 2023-11-21 | S Sale |
See Remark Officer |
1,850
-3.8%
1.98USD 3,661 |
1,850 -3.8% | 1.98 | USD 3,661 | |
| 2023-10-26 | 2023-10-24 | B Purchase |
Frazier Life Sciences VIII, L.P. Large shareholder |
80,000
+0.9%
2.50USD 200,000 |
80,000 +0.9% | 2.50 | USD 200,000 | |
| 2023-08-22 | 2023-08-21 | S Sale |
See Remarks Officer |
1,305
-2.2%
7.04USD 9,187 |
1,305 -2.2% | 7.04 | USD 9,187 | |
| 2023-08-22 | 2023-08-21 | S Sale |
See Remarks Officer |
300
-0.5%
7.05USD 2,115 |
300 -0.5% | 7.05 | USD 2,115 | |
| 2023-12-01 | 2023-05-31 | PP Planned purchase |
See Remarks Executive Director |
1,463
+0.3%
6.38USD 9,334 |
1,463 +0.3% | 6.38 | USD 9,334 | |
| 2023-06-02 | 2023-05-31 | S Sale |
See Remark Officer |
1,830
-4.2%
7.80USD 14,278 |
1,830 -4.2% | 7.80 | USD 14,278 | |
| 2023-04-18 | 2023-04-17 | PS Planned sale | Non-Executive Director |
8,500
-4.9%
13.97USD 118,728 |
8,500 -4.9% | 13.97 | USD 118,728 | |
| 2023-04-10 | 2023-04-06 | PS Planned sale | Non-Executive Director |
8,500
-4.9%
12.01USD 102,085 |
8,500 -4.9% | 12.01 | USD 102,085 |